Healthcare Market Research Worldwide

Solid Tumors

Solid Tumors

Solid tumors represent one of the most complex and competitive areas in oncology, with an expanding pipeline of novel mechanisms, rapid scientific advancement, and growing pressure on access, sequencing, and differentiation. At APLUSA, we bring clarity to this complexity by combining real-world patient data, market trackers, and advanced behavioral insights.

Our solid tumor expertise spans major tumor types and treatment settings, supporting pharma and biotech teams in sizing opportunities, refining value narratives, understanding treatment decision-making, and tracking evolving market dynamics across the product lifecycle.

Core focus areas

  • Women’s Cancer: Breast / Ovarian / Endometrial
  • Men’s Cancer: Prostate
  • Melanoma
  • Bladder
  • Renal
  • Mesothelioma
  • NSCLC (Non-Small Cell Lung Cancer)
  • Biosimilars vs. Branded Therapies
Back

Paul Taylor

Senior Director Strategic Partnerships​

Paul brings over 20 years of pharmaceutical business development and client partnership experience across Europe, the US, Japan, and Latin America. He has a long term exposure to longitudinal hospital data and strong expertise in oncology, neurology, and other complex and emerging therapeutic areas.

At APLUSA, Paul focuses on building and growing strategic client collaborations.. He works closely with clients, external partners and internal teams to create long-term value, unlock new mutually beneficial opportunities, and ensure joint initiatives translate into concrete business impact for clients.

Most people we know have been affected by cancer or a life-changing medical condition in some way. By working collaboratively and combining our efforts, we can improve patient outcomes—and we must all believe in our ability to make a meaningful difference for patients. Paul has a passion for sport (Cricket) and travel as well as trying to play golf!

Back

Manuel Guzman Martin

Global Head of Commercial

Manuel is a senior healthcare market research and commercial leader with strong expertise in client engagement and growth. He has built his career across pharma, biotech and medtech, with a particular focus on oncology, immunology and cardio-metabolic diseases. His background spans senior roles in global consulting as well as in-house positions, giving him a grounded view of both strategy and execution.

At APLUSA, Manuel leads the global commercial organization, partnering with Key Account Directors, Customer Success Managers and Strategic Partnership Directors to drive sustainable growth by staying close to client needs and market dynamics. He works with teams to translate complex business and scientific questions into clear, decision-enabling strategies, while building long-term, trusted partnerships and ensuring high levels of client satisfaction. He also plays a key role in shaping APLUSA’s commercial strategy and international expansion.

Driven by curiosity and collaboration, Manuel is motivated by helping teams and clients turn robust insights into confident decisions that make a real impact.

Back

Mélanie Marrot, PhD

Vice President, Client Engagement France

Mélanie is a PhD-trained scientist who moved from academic research into healthcare marketing and has built more than 15 years of experience in medical market research. She combines strong analytical depth with a practical understanding of how pharma markets work, and is known for anticipating client needs and turning complex data into clear, decision-ready insights across a wide range of therapeutic areas.

At APLUSA, Mélanie is a key client-facing leader for France, partnering closely with teams to design the right methodologies, guide studies from proposal to recommendation, and ensure consistently high scientific and strategic standards. She plays an active role in strengthening long-term client relationships, leading high-volume programs smoothly, and bringing added value through sharp interpretation and tailored recommendations.

A mountaineer at heart, Mélanie builds client relationships as true partnerships, grounded in trust, collaboration, and shared ambition, bringing the resilience, discipline, and adaptability of the mountains to every project.